Chicago & Midwest CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
UChicago Medicine Launches Clinical Trial on Possible COVID-19 Treatment
The University of Chicago Medicine is launching a clinical trial to study whether blood plasma from people who have recovered from COVID-19 can be used to treat patients who are still in the hospital with severe disease symptoms.
The initial study will investigate the safety and feasibility of procedures for identifying donors, collecting plasma donations and administering transfusions.
“This trial is just the first step, but hopefully it will help us determine if plasma transfusions can be a treatment for critically ill patients with COVID-19,” said UChicago Medicine’s Maria Lucia Madariaga, MD, who is leading the clinical trial.
Hospitals globally have begun testing convalescent plasma as a potential treatment for COVID-19. “At UChicago, we are really fortunate that we have all the teams required to perform a convalescent plasma trial under one roof — Biological Sciences Division, Blood Bank, Department of Medicine, Transplant Institute and the Department of Surgery,” said Madariaga.
For comments, questions or concerns, please contact Paul Bubny
